New tech promises easier cervical cancer screening

May 31, 2017 by Ken Kingery
A prototype of the speculum-free "pocket colposcope" being developed by Duke University produces images on a smart phone or laptop and can make cervical cancer screening more accessible to women living in low-resource areas. Credit: Duke University

Duke University researchers have developed a handheld device for cervical cancer screening that promises to do away with uncomfortable speculums and high-cost colposcopes.

The "pocket colposcope" is a slender wand that can connect to many devices, including laptops or cell phones.

If widely adopted, might even use the device to self-screen, transforming screening and cure rates in low-income countries and regions of the United States, where is most prevalent.

Cervical cancer is the fourth most common cancer in women, with more than 500,000 new cases occurring annually worldwide. In the United States, physicians diagnose more than 10,000 cases each year. While more than 4,000 American women die of the disease each year, the mortality rate has dropped more than 50 percent in the past four decades, largely due to the advent of well-organized screening and diagnostic programs.

While the Pap smear can be performed by a non-specialist, colposcopy requires visualization of the cervix, relying on highly trained professionals and expensive equipment that is not easily accessible to underserved populations. These factors make cervical cancer more prevalent in women living in low socioeconomic communities.

In a new paper published on May 31 in the journal PLOS One, researchers from Duke believe they have found a better way.

"The mortality rate of cervical cancer should absolutely be zero percent because we have all the tools to see and treat it," said Nimmi Ramanujam, the Robert W. Carr, Jr., Professor of Biomedical Engineering at Duke. "But it isn't. That is in part because women do not receive screening or do not follow up on a positive screening to have colposcopy performed at a referral clinic. We need to bring colposcopy to women so that we can reduce this complicated string of actions into a single touch point."

Mercy Asiedu, a graduate student in Duke's Global Women's Health Technologies Center, shows the prototype speculum-free "pocket colposcope" that is currently being beta tested in several hospitals across the United States. Credit: Duke University

Current standard practices for cervical cancer screening require three things: a speculum, a colposcope and a trained professional to administer the test.

The speculum is a metal device designed to spread the vaginal walls apart. The colposcope is a magnified telescopic device and camera designed to allow medical professionals to look through the speculum to see the cervix, which is located three to six inches inside the vagina. Colposcopes and people who know how to use them are difficult to find in many low-income regions, both domestically and internationally.

Ramanujam believes she can replace at least two of these requirements. Her laboratory has developed an all-in-one device that resembles a pocket-sized tampon with lights and a camera at one end. Health providers—or even women themselves—are able to capture images of the cervix using the rounded tip of the device to manipulate its position if necessary. The device also includes a channel through which contrast agents used for the cervical screening procedure can be applied.

"We recruited 15 volunteers on Duke's campus to try out the new integrated speculum-colposcope design," said Mercy Asiedu, a graduate student working on the project in Ramanujam's lab. "Nearly everyone said they preferred it to a traditional speculum and more than 80 percent of the women who tried the were able to get a good image. Those that couldn't felt that they just needed some practice."

Ramanujam and Asiedu are now working on clinical trials to see how their design stacks up against the traditional colposcopy used with a speculum. By using both methods to visualize the cervix, the researchers will be able to make a direct comparison.

Asiedu is also working to automate the screening process. By using image processing and machine learning to teach computers how to spot signs of precancerous and cancerous cells, Asiedu hopes to remove the need for a trained physician at any point in the process and shift the task to midwives, community health workers and even the women themselves.

"There have been a few other attempts to come up with a better solution, but none of them have succeeded," said Asiedu. "One design using an inflatable cylinder proved just as uncomfortable as a traditional speculum. Another using directed airflow is just as bulky and expensive as a modern colposcope. With our handheld, low-cost design, we're hoping to redefine the entire procedure."

Explore further: Screening, HPV vaccine can prevent cervical cancer: FDA

More information: Mercy Nyamewaa Asiedu et al, Design and preliminary analysis of a vaginal inserter for speculum-free cervical cancer screening, PLOS ONE (2017). DOI: 10.1371/journal.pone.0177782

Related Stories

Screening, HPV vaccine can prevent cervical cancer: FDA

February 8, 2017
(HealthDay)—Women can reduce their risk of cervical cancer through vaccination and screening, the U.S. Food and Drug Administration says.

Women should continue cervical cancer screening as they approach age 65

May 1, 2017
Cervical cancer is often thought of as a disease that primarily affects young women. Because of this, many older women fail to keep up with appropriate screening as they age. While current guidelines indicate that screening ...

Five myths about cervical screening that refuse to die

March 10, 2017
The online petition against changes to Australia's cervical cancer screening program has revealed more than 70,000 people (most of whom we could assume are women) are deeply concerned about what the upcoming changes mean.

More than two-thirds of cervical cancer deaths prevented by screening

September 19, 2016
Cervical screening prevents 70 per cent of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83 per cent, according to research led by Queen Mary University of London (QMUL).

ACP releases advice for the proper time, test, and interval for cervical cancer screening

April 30, 2015
The American College of Physicians (ACP) today released clinical advice aimed at reducing overuse of cervical cancer screening in average risk women without symptoms. "Cervical Cancer Screening in Average Risk Women" is ...

Cervical cancer gene discovery may boost remedy quest

January 24, 2017
Cervical cancer comes in subtypes, said a study Monday that may boost the quest for life-saving treatments for a disease experts said is killing more women than previously thought.

Recommended for you

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

Biology of childhood brain tumor subtypes offers clues to precision treatments

October 17, 2017
Researchers investigating pediatric low-grade gliomas (PLGG), the most common type of brain tumor in children, have discovered key biological differences in how mutated genes combine with other genes to drive this childhood ...

New assay may boost targeted treatment of non-Hodgkin lymphoma

October 17, 2017
Diffuse large B-cell lymphoma (DLBCL) is an aggressive cancer and the most frequently diagnosed non-Hodgkin lymphoma worldwide (nearly 40% of cases). Recent advancements indicate that both the prognosis and choice of treatment ...

Bolstering fat cells offers potential new leukemia treatment

October 16, 2017
Killing cancer cells indirectly by powering up fat cells in the bone marrow could help acute myeloid leukemia patients, according to a new study from McMaster University.

Study reveals complex biology, gender differences, in kidney cancer

October 13, 2017
A new study is believed to be the first to describe the unique role of androgens in kidney cancer, and it suggests that a new approach to treatment, targeting the androgen receptor (AR), is worth further investigation.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.